Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment

CA Holmstedt, TN Turan, MI Chimowitz - The Lancet Neurology, 2013 - thelancet.com
Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high …

The role of biomarkers in atherothrombotic stroke—A systematic review

S Andone, Z Bajko, A Motataianu, O Mosora… - International Journal of …, 2021 - mdpi.com
Stroke represents the primary debilitating disease in adults and is the second-highest cause
of death worldwide. Atherosclerosis, the most prevalent etiology for vascular conditions, is a …

[HTML][HTML] Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque

G Sarlon-Bartoli, A Boudes, C Buffat, MA Bartoli… - European Journal of …, 2012 - Elsevier
OBJECTIVE: To test plasma levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) in
patients with high-grade carotid stenosis according to plaque histology. METHODS: This …

The elevated lipoprotein-associated phospholipase A2 activity is associated with the occurrence and recurrence of acute cerebral infarction

L Wei, Z Ke, Y Zhao, Z Cai - Neuroreport, 2017 - journals.lww.com
There is a strong association between lipoprotein-associated phospholipase A 2 (Lp-PLA 2)
levels and atherosclerosis-related diseases. The aim of this study was to investigate the role …

Lipoxygenase: an emerging target for stroke therapy

K Leyen - CNS & Neurological Disorders-Drug Targets …, 2013 - ingentaconnect.com
Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in
part by the continuing necessity to improve acute stroke care, and in part by the identification …

The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A2: a systematic …

Y Tian, H Jia, S Li, Y Wu, L Guo, G Tan, B Li - Medicine, 2017 - journals.lww.com
Background: Studies on stroke and lipoprotein-associated phospholipase A 2 (Lp-PLA 2)
have produced conflicting results. Objective: The aim of the study was to assess the …

Elevated lipoprotein-associated phospholipase A2 is associated with intracranial atherosclerosis

Y Wang, G Liu, H Song, C Cao, X Ji, G Cao - Frontiers in Neurology, 2022 - frontiersin.org
Background Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory factor
in the pathogenesis of atherosclerotic plaque and is associated with an increased risk of …

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia

B Sun, Y Xie, J Jiang, Y Wang, X Xu, C Zhao… - Lipids in health and …, 2015 - Springer
Background Cardio-protective effect of fibrate therapy is controversial and current research
is to evaluate the effect of fenofibrate therapy on rats with hypertriglycemia. Methods Rats …

Diagnostic value of combined serological markers in the detection of acute cerebral infarction

X Zhao, M Zhao, B Pang, Y Zhu, J Liu - Medicine, 2021 - journals.lww.com
Diagnostic value of combined serological markers in the dete... : Medicine Diagnostic value of
combined serological markers in the detection of acute cerebral infarction : Medicine Log in or …

Is there a consistent association between coronary heart disease and ischemic stroke caused by intracranial atherosclerosis?

AB Conforto, CC Leite, CH Nomura… - Arquivos de neuro …, 2013 - SciELO Brasil
Coronary heart disease and ischemic stroke are frequent coexistent conditions that share
risk factors and pose major burdens to global health. Even though a clear relation has been …